|
Heparin
For the latest updates, visit our Heparin Blog by
clicking here or by contacting us free of charge at our toll-free number (888) 841-9623.
 On February 14, 2008, Zoll, Kranz & Borgess, LLC was the first law firm in the nation to file suit against Baxter Healthcare Corporation and other related companies regarding contaminated batches of its drug, Heparin. We are continuing to lead the way with multiple cases filed in federal court and have ongoing investigations into possible cases both in and outside Ohio.
On May 29, 2008, Zoll, Kranz & Borgess, LLC argued before the United States Judicial Panel on Multi-District Litigation that the Heparin Products Liability Litigation be transferred to the Northern District of Ohio, located in Toledo, Ohio, before the Honorable Chief Judge James G. Carr. Other districts, including the Southern District of Illinois, District of New Jersey, Southern District of Florida, the District of Puerto Rico, and the Northern District of California, were suggested by Baxter Healthcare Corp., Scientific Protein Laboratories, LLC, and other parties.
On June 6, 2008, the United States Judicial Panel on Multi-District Litigation issued a transfer order, transferring the Heparin Multi-District Litigation MDL No. 1953 to the Northern District of Ohio, before the Honorable Chief Judge James G. Carr. To obtain a copy of this order,
CLICK HERE.
Our law firm was also honored when three of our clients, Leroy Hubley, Colleen Hubley and Johanna Staples, were invited by the U.S. House Commerce Committee on Energy and Commerce (one of the oldest standing committees of the U.S. House of Representatives) to speak on April 29, 2008, at a hearing entitled, “The Heparin Disaster: Chinese Counterfeits and American Failures.”
Panel
I (Witnesses: David Nelson, Senior Investigator for the Committee on
Energy and Commerce, Colleen Hubley, Leroy Hubley, and Johanna Marie
Staples)
Panel
II (Witnesses: Janet Woodcock, Director of the FDA’s Center for Drug
Evaluation and Research, Deborah M. Autor, Director of FDA’s Office of
Compliance, and Regina T. Brown, Consumer Safter Officer of the FDA’s
Division of Field Investigations)
Panels
III and IV (Witnesses: Robert Parkinson, CEO and President of Baxter
International, Inc., David Strunce, CEO of Scientific Protein
Laboratories, Yan Wang, Ph.D., Vice President of Business Development and
Research at Scientific Protein Laboratories, and Clive Meanwell, CEO of
The Medicines Co.)
In
addition, to view the written statements submitted by Leroy Hubley,
Colleen Hubley Johanna Staples, and other witnesses please click on their
name below:
Additional
information regarding the recall of contaminated heparin and subsequent
litigation can be obtained by clicking on the links below:
Please contact our law office at our toll-free number (888) 841-9623
or by email at pamela@toledolaw.com
if you or someone close to you may have been given heparin during dialysis or during any other procedure, and experienced any of the following symptoms or death:
-
Oral swelling
-
Abdominal pain
-
Burning sensation
-
Chest pain
-
Diarrhea
-
Dizziness
-
Drug ineffectiveness
-
Painful, difficult, or disturbed digestion
-
Dyspnea [unpleasant or uncomfortable breathing]
-
Erythema [redness of the skin]
-
Flushing
-
Headache
-
Hyperhidrosis [excessive sweating]
-
Hypoesthesia [reduced sense of touch or sensation]
-
Increased lacrimation [production, secretion, and shedding of tears]
-
Loss of consciousness
-
Malaise [general discomfort or uneasiness]
-
Nausea
-
Pallor
-
Palpitations
-
Paresthesia [tingling, pricking, or numbness of a person's skin]
-
Pharyngeal edema [swelling in throat]
-
Restlessness
-
Vomiting/retching
-
Shortness of breath
-
Stomach discomfort
-
Tachycardia [rapid beating of the heart]
-
Thirst
-
Trismus [Inability to open the mouth fully]
-
Unresponsiveness to stimuli
-
Severe hypotension [abnormally low blood pressure]
Again, you can contact our law office at our toll-free number (888) 841-9623 or by email to
pamela@toledolaw.com. There will not be a charge for this call.
|
